Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.
The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations.
Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard.
Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion.
This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| New York Facility - Skin Cell Deployment | Experimental | Humanoid units deployed in patient intake and sanitation roles. Enhanced with keratinocyte-based skin cell dips to improve tactile sensitivity and surface regeneration. Assigned Roles: Intake assistant, sanitation technician Biometric Focus: Motor function, ESG compliance |
|
| Austin Facility - Stem Cell Cognitive Enhancement | Experimental | Humanoid units deployed in mobility and R&D support roles. Enhanced with iPSC-derived stem cell dips targeting neural responsiveness and adaptive learning. Assigned Roles: Mobility assistant, lab technician Biometric Focus: Cognitive response, biotech retention |
|
| Frankfurt Facility - ESG Optimization | Experimental | Humanoid units deployed in ESG-linked sanitation and logistics roles. Monitored for energy usage, carbon offset, and protocol adherence. Assigned Roles: ESG sanitation, logistics handler Biometric Focus: ESG compliance, human interaction |
|
| Tokyo Facility - Wage Token Calibration | Experimental | Humanoid units deployed in public interface and intake roles. Wage tokens minted based on biometric audit scores and task completion. Assigned Roles: Receptionist, intake coordinator Biometric Focus: Wage token distribution, interaction scoring |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Skin Cell Dip | Biological | Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Biometric Audit Score ≥85 Across Five Performance Dimensions | This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling. | Measured at Day 30 Post-Deployment |
| Measure | Description | Time Frame |
|---|---|---|
| ESG Audit Compliance Score ≥90 | Measured at Day 60 Post-Deployment | Humanoid units are evaluated for ESG-linked performance including energy usage, sanitation protocol adherence, and carbon offset metrics. Scores are published to the coalition dashboard and notarized via SHA-256. Units scoring ≥90 contribute to DAO-backe |
Not provided
Inclusion Criteria:
- Age 18-75 years
Able to provide informed consent
Facility staff, clinical auditors, ESG observers, or coalition stakeholders
Willing to interact with humanoid robotics in clinical workflows
Available for biometric feedback and observational logging over 90 days
Exclusion Criteria:
- Cognitive impairment preventing informed consent
Active infectious disease requiring isolation
Prior adverse reaction to biotech-enhanced robotics
Involvement in conflicting clinical trials
Inability to comply with protocol procedures or coalition transparency requirements
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gavin C Solomon, President & CEO | Truway Health, Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016 | New York | New York | 10016 | United States | ||
Not provided
| Label | URL |
|---|---|
| health-trial | View source |
| ipd-sharing | View source |
| coalition-dashboard | View source |
| ID | Type | URL | Comment |
|---|---|---|---|
| De-identified biometric audit | Individual Participant Data Set | View IPD |
Individual participant data (IPD) collected during this trial-including biometric audit scores, ESG compliance metrics, and wage token distribution logs-will be shared with qualified researchers upon request. Data will be de-identified, SHA-256 notarized, and made available through Truway Health's coalition dashboard and secure data access portal. Access will require submission of a research proposal, DAO approval, and compliance with coalition transparency protocols.
IPD and supporting documents will be available starting April 1, 2026, following primary study completion. Access will remain open for 5 years, until April 1, 2031, via Truway Health's secure coalition dashboard and data access portal.
Qualified researchers, coalition partners, and regulatory agencies may request access to de-identified IPD, biometric scores, ESG metrics, wage token logs, and analytic code. Access requires submission of a research proposal, DAO approval, and compliance with Truway Health's transparency and data governance protocols.
Not provided
Humanoid robotics units are deployed across multiple metro healthcare facilities in parallel. Each facility represents a distinct intervention arm with tailored deployment protocols, biotech integration (skin/stem cell dips), and wage token logic. Outcomes are measured independently across arms using biometric audit scoring and ESG compliance metrics.
Not provided
Not provided
N/A - All stakeholders, including facility managers, auditors, and coalition observers, are aware of humanoid deployment and performance tracking.
Not provided
| Stem Cell Dip | Biological | iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning. |
|
| Wage Token Distribution | Other | HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion. |
|
|
| ESG Compliance Monitoring, Operational protocol | Behavioral | Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard. |
|
| Wage Token Distribution Volume per Unit |
Tracks the volume of HumanoidWage (HMW) tokens minted and distributed to each humanoid unit based on biometric audit scores and task completion. Token flow is logged on-chain and used to calibrate coalition wage pools and reinvestment logic. |
| Continuous Monitoring Over 90 Days |
| Clinical Workflow Efficiency Increase ≥15% | Assesses improvements in patient intake speed, sanitation cycle time, and mobility assistance throughput across facilities. Benchmarked against pre-deployment baselines and validated by coalition auditors. | Measured at Day 90 Post-Deployment |
| Coalition Retrofit Clinic - Austin, TX |
| Austin |
| Texas |
| 73301 |
| United States |
| ESG Compliance Lab | Frankfurt | 60435 | Germany |
| Public Interface Pilot | Tokyo | 100-1000 | Japan |
truwayhealth.com |
| ESG compliance logs | Individual Participant Data Set | View IPD | truwayhealth.com |
| Wage token minting and transfe | Individual Participant Data Set | View IPD | truwayhealth.com |
| SHA-256 notarized study protoc | Individual Participant Data Set | View IPD | truwayhealth.com |
| Statistical analysis plan (SAP | Individual Participant Data Set | View IPD | truwayhealth.com |
| Informed consent form (ICF) | Individual Participant Data Set | View IPD | truwayhealth.com |
| Clinical study report (CSR) | Individual Participant Data Set | View IPD | truwayhealth.com |
| Analytic code for biometric sc | Individual Participant Data Set | View IPD | truwayhealth.com |